Home › Focal Segmental Glomerulosclerosis › Maryland
Focal Segmental Glomerulosclerosis clinical trials in Maryland
4 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in Maryland.
Cities in Maryland
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 115 · All sexes · Updated Sep 29, 2026 · NCT06664814A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT07220083NEPTUNE Match Study
- Johns Hopkins Medicine, Baltimore
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Johns Hopkins Medical Institute, Baltimore
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.